FDA guidelines for preclinical evaluation of radiopharmaceuticals
10.3760/cma.j.issn.2095-2848.2019.01.015
- VernacularTitle:美国FDA放射性药物非临床评价指导原则
- Author:
Liqun HUANG
1
;
Wenli XU
;
Jingjing YIN
;
Shufang LI
;
Weibin LI
;
Jianhua WEN
;
Quan AN
Author Information
1. 中国辐射防护研究院放射医学与环境医学研究所、药物毒理与放射损伤药物山西省重点实验室
- Keywords:
Radiopharmaceuticals;
United States Food and Drug Administration;
Drug toxicity;
Drug evaluation;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2019;39(1):49-52
- CountryChina
- Language:Chinese
-
Abstract:
Preclinical evaluation is related to the clinical safety of radiopharmaceuticals.There are different research foci on preclinical evaluation of different radiopharmaceuticals.This article summarizes the Food and Drug Administration (FDA) preclinical evaluation guidelines of diagnostic and therapeutic radiopharmaceuticals,in order to provide reference for domestic research and preclinical evaluation of radiopharmaceuticals.
